Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finafloxacin in cUTI and Acute Pyelonephritis
NCT01928433Phase 2Completed
- Sponsor
- MerLion Pharmaceuticals
- Start
- Dec 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finafloxacin in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by MerLion Pharmaceuticals. Started Dec 2012; status: completed.
02
Drugs
finafloxacin
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT01928433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928433.